Author Search Results

Kumaravel Somasundaram

Kumaravel Somasundaram (born 8 October 1962) is an Indian cancer biologist and a professor at the Department of Microbiology and Cell Biology of the Indian Institute of Science. Known for his studies on the therapeutics of Glioblastoma, Somasunderam is an elected fellow of all the three major Indian science academies namely, the National Academy of Sciences, India, the Indian Academy of Sciences and the Indian National Science Academy. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2006. Provided by Wikipedia

1

Global RNA editome landscape discovers reduced RNA editing in glioma: loss of editing of gamma-amino butyric acid receptor alpha subunit 3 (GABRA3) favors glioma migration and inva...

by Vikas Patil, Jagriti Pal, Kulandaivelu Mahalingam, Kumaravel Somasundaram
Published 2020-09-01

Get full text

Article
2

A ten-microRNA expression signature predicts survival in glioblastoma.

by Sujaya Srinivasan, Irene Rosita Pia Patric, Kumaravel Somasundaram
Published 2011-01-01

Get full text

Article
3

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas

by Yashna Paul, Baisakhi Mondal, Vikas Patil, Kumaravel Somasundaram
Published 2017-04-01

Get full text

Article
4

<em>N</em><sup>6</sup>-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Sig...

by Abhirami Visvanathan, Vikas Patil, Shibla Abdulla, Jörg D. Hoheisel, Kumaravel Somasundaram
Published 2019-02-01

Get full text

Article
5

An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.

by Mamatha B Nijaguna, Vikas Patil, Alangar S Hegde, Bangalore A Chandramouli, Arimappamagan Arivazhagan, Vani Santosh, Kumaravel Somasundaram
Published 2015-01-01

Get full text

Article
6

miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.

by Soumya Alige Mahabala Rao, Arivazhagan Arimappamagan, Paritosh Pandey, Vani Santosh, Alangar Sathyaranjandas Hegde, Bangalore Ashwathnarayanara Chandramouli, Kumaravel Somasundaram
Published 2013-01-01

Get full text

Article
7

A 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma.

by Soumya Alige Mahabala Rao, Sujaya Srinivasan, Irene Rosita Pia Patric, Alangar Sathyaranjandas Hegde, Bangalore Ashwathnarayanara Chandramouli, Arivazhagan Arimappamagan, Vani Santosh, Paturu Kondaiah, Manchanahalli R Sathyanarayana Rao, Kumaravel Somasundaram
Published 2014-01-01

Get full text

Article
8

A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group.

by Arivazhagan Arimappamagan, Kumaravel Somasundaram, Kandavel Thennarasu, Sreekanthreddy Peddagangannagari, Harish Srinivasan, Bangalore C Shailaja, Cini Samuel, Irene Rosita Pia Patric, Sudhanshu Shukla, Balaram Thota, Krishnarao Venkatesh Prasanna, Paritosh Pandey, Anandh Balasubramaniam, Vani Santosh, Bangalore Ashwathnarayanara Chandramouli, Alangar Sathyaranjandas Hegde, Paturu Kondaiah, Manchanahalli R Sathyanarayana Rao
Published 2013-01-01

Get full text

Article